Cargando…

Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study

BACKGROUND: Acellular pertussis vaccine studies postulate that waning protection, particularly after the adolescent booster, is a major contributor to the increasing US pertussis incidence. However, these studies reported relative (ie, vs a population given prior doses of pertussis vaccine), not abs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chit, Ayman, Zivaripiran, Hossein, Shin, Thomas, Lee, Jason K. H., Tomovici, Antigona, Macina, Denis, Johnson, David R., Decker, Michael D., Wu, Jianhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005504/ https://www.ncbi.nlm.nih.gov/pubmed/29912887 http://dx.doi.org/10.1371/journal.pone.0197970

Ejemplares similares

Revisiting the epidemiology of pertussis in Canada, 1924–2015: a literature review, evidence synthesis, and modeling study
por: Thommes, Edward, et al.
Publicado: (2020)

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

The Clinical Burden of Clostridioides difficile in Ontario, Canada
por: Pereira, Jennifer A, et al.
Publicado: (2019)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
por: Esposito, Susanna, et al.
Publicado: (2019)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
por: Knuutila, Aapo, et al.
Publicado: (2023)

Acellular Pertussis Vaccine Components: Today and Tomorrow
por: Dewan, Kalyan K., et al.
Publicado: (2020)

Acellular pertussis vaccine efficacy: An updated systematic review and meta –analysis
por: Mansour-Ghanaei, Roxana, et al.
Publicado: (2016)

Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
por: Hara, Megumi, et al.
Publicado: (2015)

Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017)

Proteomics of Bordetella pertussis whole-cell and acellular vaccines
por: Möller, Jens, et al.
Publicado: (2019)

Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy
por: Alghounaim, Mohammad, et al.
Publicado: (2022)

Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines
por: Zomer, Aldert, et al.
Publicado: (2018)

Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
por: Abu-Raya, Bahaa, et al.
Publicado: (2018)

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice
por: Holubová, Jana, et al.
Publicado: (2020)

Is it time to administer acellular pertussis vaccine to childbearing age/pregnant women in all areas using whole-cell pertussis vaccination schedule?
por: Esteghamati, Abdoulreza, et al.
Publicado: (2021)

Oral Diazepam in Febrile Seizures Following Acellular Pertussis Vaccination
por: Ghazavi, Mohammadreza, et al.
Publicado: (2019)

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
por: Boehm, Dylan T., et al.
Publicado: (2019)

Erratum to: Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
Publicado: (2021)

Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice
por: Wolf, M. Allison, et al.
Publicado: (2021)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
por: van Schuppen, Evi, et al.
Publicado: (2022)

Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring
por: Dubois, Violaine, et al.
Publicado: (2023)

Can vaccines control bacterial virulence and pathogenicity? Bordetella pertussis: the advantage of fitness over virulence
por: Guiso, Nicole, et al.
Publicado: (2022)

Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019
por: Brandal, Lin T., et al.
Publicado: (2022)

Evaluation of acellular pertussis vaccine: comparisons among different strains of mice
por: Wei, Jie, et al.
Publicado: (2023)

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
por: Baxter, Roger, et al.
Publicado: (2016)

Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage
por: Dubois, Violaine, et al.
Publicado: (2021)

Safety testing of acellular pertussis vaccines: Use of animals and 3Rs alternatives
por: Hoonakker, Marieke, et al.
Publicado: (2017)

Development and implementation of standardized method for detecting immunogenicity of acellular pertussis vaccines in Korea
por: Park, Chulmin, et al.
Publicado: (2019)

Choosing from Whole Cell and Acellular Pertussis Vaccines-Dilemma for the Developing Countries
por: SYED, Muhammad Ali
Publicado: (2017)

Differences in epitope‐specific antibodies to pertussis toxin after infection and acellular vaccinations
por: Knuutila, Aapo, et al.
Publicado: (2020)

Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review
por: Vygen-Bonnet, Sabine, et al.
Publicado: (2020)

Multiplex Point-of-Care Tests for the Determination of Antibodies after Acellular Pertussis Vaccination
por: Knuutila, Aapo, et al.
Publicado: (2020)

Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0–9 Years with Pertussis in Catalonia (Spain)
por: Plans-Rubió, Pedro, et al.
Publicado: (2018)

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose
por: Halperin, Scott A, et al.
Publicado: (2018)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
por: Leroux-Roels, Geert, et al.
Publicado: (2017)

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands
por: Versteegen, Pauline, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_je7kh6tsdjheeigpjnbf51i6u5